Income Tax Expense	3 Months Ended
Mar. 31, 2020
Income Tax Disclosure [Abstract]
Income Tax Expense	15. INCOME TAX EXPENSE The Company recorded an income tax benefit of $4.0 million and $27.6 million for the three months ended March 31, 2020 and 2019, respectively. The effective tax rate for the three months ended March 31, 2020 was 3.6% recorded on a loss from continuing operations before taxes of $112.4 million. The lower effective tax rate for the first quarter of 2020, was primarily effected by the impairment of goodwill and intangible assets, which were largely not deductible for tax purposes. The tax benefit associated with the $122.2 million impairment charge was limited to $9 million, and is a discrete item for the first quarter of 2020. We will continue to refine our estimate of the tax effect from the impairment through the year. The effective tax rate for the three months ended March 31, 2019 was (217.6%) on income from continuing operations before tax of $12.7 million. The income tax benefit recorded in the first quarter of 2019 is the result of a corporate restructuring which resulted in a net deferred tax benefit of $58.5 million, which was reduced by tax expense of $26.7 million related to unremitted earnings of foreign subsidiaries that we no longer consider to be indefinitely reinvested, each of which was a discrete item to the quarter ended March 31, 2019. Income tax expense will continue to be impacted by changes in activity levels in jurisdictions with differing tax rates.

Income Tax Expense

3 Months Ended

Mar. 31, 2020

15. INCOME TAX EXPENSE

The Company recorded an income tax benefit of $4.0 million and $27.6 million for the three months ended March 31, 2020 and 2019, respectively. The effective tax rate for the three months ended March 31, 2020 was 3.6% recorded on a loss from continuing operations before taxes of $112.4 million. The lower effective tax rate for the first quarter of 2020, was primarily effected by the impairment of goodwill and intangible assets, which were largely not deductible for tax purposes. The tax benefit associated with the $122.2 million impairment charge was limited to $9 million, and is a discrete item for the first quarter of 2020. We will continue to refine our estimate of the tax effect from the impairment through the year. The effective tax rate for the three months ended March 31, 2019 was (217.6%) on income from continuing operations before tax of $12.7 million. The income tax benefit recorded in the first quarter of 2019 is the result of a corporate restructuring which resulted in a net deferred tax benefit of $58.5 million, which was reduced by tax expense of $26.7 million related to unremitted earnings of foreign subsidiaries that we no longer consider to be indefinitely reinvested, each of which was a discrete item to the quarter ended March 31, 2019. Income tax expense will continue to be impacted by changes in activity levels in jurisdictions with differing tax rates.